Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.
Bonito Biosciences has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
Bonito Biosciences's investors include Lightstone Ventures, Anterra Capital, Jazz Venture Partners.
Bonito Biosciences is headquartered in Waltham, United States.
Bonito Biosciences is a biotechnology research firm specializing in tissue-selective drug delivery for oligonucleotides and macromolecules.
Bonito Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bonito Biosciences — Funding & Investors." VCBacked, May 31, 2024, https://www.vcbacked.co/company/bonito-biosciences. Accessed November 15, 2026.
VCBacked. (2024). Bonito Biosciences — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/bonito-biosciences
{{cite web |title=Bonito Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/bonito-biosciences |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Bonito Biosciences? Request a listing update